An observational study in SARS-CoV 2 Pneumonia, sponsored by University Hospital, Tours. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-04.
Sponsored by University Hospital, Tours · Observational
Long term follow up of patients included in a randomized controlled trial evaluating awake prone positioning among patients suffering SARS-CoV2 pneumonia (NCT04358939)
All patients included in the initial trial who survived and were not lost to follow up at 28 days will be invited for a telephone interview to collect data on long term quality of life.
1,597 studies on the registry are indexed under Respiratory Distress Syndrome; 312 are open to participants now.
This study's enrollment of 137 is above the median of 100 across 540 observational studies indexed under Respiratory Distress Syndrome.
Browse Respiratory Distress Syndrome studies →University Hospital, Tours is the lead sponsor of 304 studies on the registry; 78 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients included in France in the randomized study "High Prone Covid" alive at day 28 (NCT04358939).
Exclusion Criteria:
telephone interview comprising a quality of life questionnaire
Other: quality of life questionnaire
telephone interview comprising a quality of life questionnaire
Other: quality of life questionnaire
telephone interview to assess mortality and quality of life in the population included in a trial
EURO QoL 5D 5L quality-of-life score
Quality of life at last follow-up, beyond 2 years after randomization, assessed by a EURO QoL 5D 5L quality-of-life score
Time frame: 2 years after randomization
Mortality at last follow-up time beyond 2 years after randomization
Time frame: an average of 2 years follow up
Assessment of autonomy
Subpart of EURO QoL 5D 5L score
Time frame: an average of 2 years follow up
Assessment of mobility
Subpart of EURO QoL 5D 5L score
Time frame: an average of 2 years follow up
Assessment of performance of daily activities
Subpart of EURO QoL 5D 5L score
Time frame: an average of 2 years follow up
Assessment of pain and discomfort
Subpart of EURO QoL 5D 5L score
Time frame: an average of 2 years follow up
Assessment of anxiety and depression
Subpart of EURO QoL 5D 5L score
Time frame: an average of 2 years follow up
Number of points on the visual analog scale
Subpart of EURO QoL 5D 5L score
Time frame: an average of 2 years follow up
Hospitalisations
Number of new hospitalizations during follow-up period
Time frame: an average of 2 years follow up
Family situation
Change of family situation
Time frame: before hospitalization in intensive care unit, then at 12, 24 months and at final follow-up.
Employment status
Change of employment status
Time frame: before hospitalization, then at 12, 24 months and at final follow-up.
Subgroup analysis:
analysis of primary endpoint, mortality, and subparts of the EURO QoL 5D 5L score in subgroups of patients who were intubated or not during follow-up in the initial meta-assay
Time frame: an average of 2 years follow up
Plan to share: Undecided
No publications or documents are linked to this record.
This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Respiratory Distress Syndrome→
University Hospital, Tours